Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis

Trisomy 14 mosaicism is a rare chromosomal abnormality. It is associated with multiple congenital anomalies. We report a 15 year-old female with an unusual karyotype with three cell lines: 47,XX,+mar/47,XX,+14/46,XX. At six months old she had short stature, cleft palate, hyperpigmented linear spots...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular cytogenetics 2014-09, Vol.7 (1), p.65, Article 65
Hauptverfasser: Salas-Labadía, Consuelo, Lieberman, Esther, Cruz-Alcívar, Roberto, Navarrete-Meneses, Pilar, Gómez, Samuel, Cantú-Reyna, Consuelo, Buiting, Karin, Durán-McKinster, Carola, Pérez-Vera, Patricia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 65
container_title Molecular cytogenetics
container_volume 7
creator Salas-Labadía, Consuelo
Lieberman, Esther
Cruz-Alcívar, Roberto
Navarrete-Meneses, Pilar
Gómez, Samuel
Cantú-Reyna, Consuelo
Buiting, Karin
Durán-McKinster, Carola
Pérez-Vera, Patricia
description Trisomy 14 mosaicism is a rare chromosomal abnormality. It is associated with multiple congenital anomalies. We report a 15 year-old female with an unusual karyotype with three cell lines: 47,XX,+mar/47,XX,+14/46,XX. At six months old she had short stature, cleft palate, hyperpigmented linear spots in arms and legs and developmental delay. At present, she has mild facial dysmorphism and moderate mental retardation. Cytogenetic analysis was performed in peripheral blood lymphocytes and in the light and dark skin following standard methods. DNAarray - Oligo 180 k was carried out using Agilent Technologies and FISH analysis was accomplished using DNA BACs probes to confirm the result obtained by DNAarray. Methylation-Specific PCR (MS-PCR) of the MEG3 promoter and microsatellite analysis were performed. Microarray analysis confirmed partial trisomy 14 mosaicism; the marker chromosome was found to be from chromosome 14, the result was confirmed with FISH. Methylation (14q32.3) and microsatellite (14q11-14q32.33) analysis were carried out and UPD was discarded. The global result was: mos 47,XX,+del(14)(q11.2)[45]/47,XX,+14[10]/46,XX[45]. This is a unique case because of the coexistence of two abnormal cell lines, including one with +14 and another with +del(14)(q11.2). To our knowledge, only three patients have been reported with trisomy 14 and another abnormal cell line. The array analysis identified the marker chromosome and characterized the breakpoint. The del(14)(q11.2) does not seem to be related to any particular phenotypic characteristic of the patient; the clinical features of our patient observed until now, can be attributed to trisomy 14 mosaicism. Nevertheless, we cannot discard the manifestation of new symptoms related to her karyotype in the future.
doi_str_mv 10.1186/s13039-014-0065-8
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4180134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A540655383</galeid><sourcerecordid>A540655383</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-90b074b995a84258fb60109223bf877d815e113c2a33079430d30e1975d1d9b63</originalsourceid><addsrcrecordid>eNptkV9LHDEUxYNUqq79AL6Ugb46mjv5M0kfCotYFQT7UJ9DJpPZRpLJNplR9ts3drdWQfKQe5NzDvfyQ-gE8BmA4OcZCCayxkBrjDmrxR46hJaVAjj_8Ko-QEc5PxQNEEE_ooOGNS1vmvYQ6R86TU77So99ZWJYezvZakoux7CpgFYhZu2My-FrZbwbnSnaIXofn-p5fVqZzRRXdrSTM38jQvTWzF6n0mm_yS4fo_1B-2w_7e4Fuv9--fPiur69u7q5WN7Wpgwz1RJ3uKWdlEwL2jAxdBwDlk1DukG0bS-AWQBiGk0IbiUluCfYgmxZD73sOFmgb9vc9dwF2xs7Tkl7tU4u6LRRUTv19md0v9QqPioKAgOhJeDLLiDF37PNk3qIcypbZAWMc0bLOPK_aqW9VW4cYgkzwWWjlowWCowIUlRn76jK6W1wJo52cOX9jQG2BpNizskOL4MDVs-w1Ra2KrDVM2wliufz641fHP_okj-2kKOX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566541099</pqid></control><display><type>article</type><title>Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>SpringerLink Journals - AutoHoldings</source><creator>Salas-Labadía, Consuelo ; Lieberman, Esther ; Cruz-Alcívar, Roberto ; Navarrete-Meneses, Pilar ; Gómez, Samuel ; Cantú-Reyna, Consuelo ; Buiting, Karin ; Durán-McKinster, Carola ; Pérez-Vera, Patricia</creator><creatorcontrib>Salas-Labadía, Consuelo ; Lieberman, Esther ; Cruz-Alcívar, Roberto ; Navarrete-Meneses, Pilar ; Gómez, Samuel ; Cantú-Reyna, Consuelo ; Buiting, Karin ; Durán-McKinster, Carola ; Pérez-Vera, Patricia</creatorcontrib><description>Trisomy 14 mosaicism is a rare chromosomal abnormality. It is associated with multiple congenital anomalies. We report a 15 year-old female with an unusual karyotype with three cell lines: 47,XX,+mar/47,XX,+14/46,XX. At six months old she had short stature, cleft palate, hyperpigmented linear spots in arms and legs and developmental delay. At present, she has mild facial dysmorphism and moderate mental retardation. Cytogenetic analysis was performed in peripheral blood lymphocytes and in the light and dark skin following standard methods. DNAarray - Oligo 180 k was carried out using Agilent Technologies and FISH analysis was accomplished using DNA BACs probes to confirm the result obtained by DNAarray. Methylation-Specific PCR (MS-PCR) of the MEG3 promoter and microsatellite analysis were performed. Microarray analysis confirmed partial trisomy 14 mosaicism; the marker chromosome was found to be from chromosome 14, the result was confirmed with FISH. Methylation (14q32.3) and microsatellite (14q11-14q32.33) analysis were carried out and UPD was discarded. The global result was: mos 47,XX,+del(14)(q11.2)[45]/47,XX,+14[10]/46,XX[45]. This is a unique case because of the coexistence of two abnormal cell lines, including one with +14 and another with +del(14)(q11.2). To our knowledge, only three patients have been reported with trisomy 14 and another abnormal cell line. The array analysis identified the marker chromosome and characterized the breakpoint. The del(14)(q11.2) does not seem to be related to any particular phenotypic characteristic of the patient; the clinical features of our patient observed until now, can be attributed to trisomy 14 mosaicism. Nevertheless, we cannot discard the manifestation of new symptoms related to her karyotype in the future.</description><identifier>ISSN: 1755-8166</identifier><identifier>EISSN: 1755-8166</identifier><identifier>DOI: 10.1186/s13039-014-0065-8</identifier><identifier>PMID: 25276227</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Case Report ; Case studies ; DNA microarrays ; Genetic aspects ; Instrument industry ; Mental illness ; Risk factors ; Skin</subject><ispartof>Molecular cytogenetics, 2014-09, Vol.7 (1), p.65, Article 65</ispartof><rights>COPYRIGHT 2014 BioMed Central Ltd.</rights><rights>2014 Salas-Labadía et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Salas-Labadía et al.; licensee BioMed Central Ltd. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-90b074b995a84258fb60109223bf877d815e113c2a33079430d30e1975d1d9b63</citedby><cites>FETCH-LOGICAL-c527t-90b074b995a84258fb60109223bf877d815e113c2a33079430d30e1975d1d9b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180134/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180134/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25276227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salas-Labadía, Consuelo</creatorcontrib><creatorcontrib>Lieberman, Esther</creatorcontrib><creatorcontrib>Cruz-Alcívar, Roberto</creatorcontrib><creatorcontrib>Navarrete-Meneses, Pilar</creatorcontrib><creatorcontrib>Gómez, Samuel</creatorcontrib><creatorcontrib>Cantú-Reyna, Consuelo</creatorcontrib><creatorcontrib>Buiting, Karin</creatorcontrib><creatorcontrib>Durán-McKinster, Carola</creatorcontrib><creatorcontrib>Pérez-Vera, Patricia</creatorcontrib><title>Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis</title><title>Molecular cytogenetics</title><addtitle>Mol Cytogenet</addtitle><description>Trisomy 14 mosaicism is a rare chromosomal abnormality. It is associated with multiple congenital anomalies. We report a 15 year-old female with an unusual karyotype with three cell lines: 47,XX,+mar/47,XX,+14/46,XX. At six months old she had short stature, cleft palate, hyperpigmented linear spots in arms and legs and developmental delay. At present, she has mild facial dysmorphism and moderate mental retardation. Cytogenetic analysis was performed in peripheral blood lymphocytes and in the light and dark skin following standard methods. DNAarray - Oligo 180 k was carried out using Agilent Technologies and FISH analysis was accomplished using DNA BACs probes to confirm the result obtained by DNAarray. Methylation-Specific PCR (MS-PCR) of the MEG3 promoter and microsatellite analysis were performed. Microarray analysis confirmed partial trisomy 14 mosaicism; the marker chromosome was found to be from chromosome 14, the result was confirmed with FISH. Methylation (14q32.3) and microsatellite (14q11-14q32.33) analysis were carried out and UPD was discarded. The global result was: mos 47,XX,+del(14)(q11.2)[45]/47,XX,+14[10]/46,XX[45]. This is a unique case because of the coexistence of two abnormal cell lines, including one with +14 and another with +del(14)(q11.2). To our knowledge, only three patients have been reported with trisomy 14 and another abnormal cell line. The array analysis identified the marker chromosome and characterized the breakpoint. The del(14)(q11.2) does not seem to be related to any particular phenotypic characteristic of the patient; the clinical features of our patient observed until now, can be attributed to trisomy 14 mosaicism. Nevertheless, we cannot discard the manifestation of new symptoms related to her karyotype in the future.</description><subject>Case Report</subject><subject>Case studies</subject><subject>DNA microarrays</subject><subject>Genetic aspects</subject><subject>Instrument industry</subject><subject>Mental illness</subject><subject>Risk factors</subject><subject>Skin</subject><issn>1755-8166</issn><issn>1755-8166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNptkV9LHDEUxYNUqq79AL6Ugb46mjv5M0kfCotYFQT7UJ9DJpPZRpLJNplR9ts3drdWQfKQe5NzDvfyQ-gE8BmA4OcZCCayxkBrjDmrxR46hJaVAjj_8Ko-QEc5PxQNEEE_ooOGNS1vmvYQ6R86TU77So99ZWJYezvZakoux7CpgFYhZu2My-FrZbwbnSnaIXofn-p5fVqZzRRXdrSTM38jQvTWzF6n0mm_yS4fo_1B-2w_7e4Fuv9--fPiur69u7q5WN7Wpgwz1RJ3uKWdlEwL2jAxdBwDlk1DukG0bS-AWQBiGk0IbiUluCfYgmxZD73sOFmgb9vc9dwF2xs7Tkl7tU4u6LRRUTv19md0v9QqPioKAgOhJeDLLiDF37PNk3qIcypbZAWMc0bLOPK_aqW9VW4cYgkzwWWjlowWCowIUlRn76jK6W1wJo52cOX9jQG2BpNizskOL4MDVs-w1Ra2KrDVM2wliufz641fHP_okj-2kKOX</recordid><startdate>20140925</startdate><enddate>20140925</enddate><creator>Salas-Labadía, Consuelo</creator><creator>Lieberman, Esther</creator><creator>Cruz-Alcívar, Roberto</creator><creator>Navarrete-Meneses, Pilar</creator><creator>Gómez, Samuel</creator><creator>Cantú-Reyna, Consuelo</creator><creator>Buiting, Karin</creator><creator>Durán-McKinster, Carola</creator><creator>Pérez-Vera, Patricia</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20140925</creationdate><title>Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis</title><author>Salas-Labadía, Consuelo ; Lieberman, Esther ; Cruz-Alcívar, Roberto ; Navarrete-Meneses, Pilar ; Gómez, Samuel ; Cantú-Reyna, Consuelo ; Buiting, Karin ; Durán-McKinster, Carola ; Pérez-Vera, Patricia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-90b074b995a84258fb60109223bf877d815e113c2a33079430d30e1975d1d9b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Case Report</topic><topic>Case studies</topic><topic>DNA microarrays</topic><topic>Genetic aspects</topic><topic>Instrument industry</topic><topic>Mental illness</topic><topic>Risk factors</topic><topic>Skin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salas-Labadía, Consuelo</creatorcontrib><creatorcontrib>Lieberman, Esther</creatorcontrib><creatorcontrib>Cruz-Alcívar, Roberto</creatorcontrib><creatorcontrib>Navarrete-Meneses, Pilar</creatorcontrib><creatorcontrib>Gómez, Samuel</creatorcontrib><creatorcontrib>Cantú-Reyna, Consuelo</creatorcontrib><creatorcontrib>Buiting, Karin</creatorcontrib><creatorcontrib>Durán-McKinster, Carola</creatorcontrib><creatorcontrib>Pérez-Vera, Patricia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular cytogenetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salas-Labadía, Consuelo</au><au>Lieberman, Esther</au><au>Cruz-Alcívar, Roberto</au><au>Navarrete-Meneses, Pilar</au><au>Gómez, Samuel</au><au>Cantú-Reyna, Consuelo</au><au>Buiting, Karin</au><au>Durán-McKinster, Carola</au><au>Pérez-Vera, Patricia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis</atitle><jtitle>Molecular cytogenetics</jtitle><addtitle>Mol Cytogenet</addtitle><date>2014-09-25</date><risdate>2014</risdate><volume>7</volume><issue>1</issue><spage>65</spage><pages>65-</pages><artnum>65</artnum><issn>1755-8166</issn><eissn>1755-8166</eissn><abstract>Trisomy 14 mosaicism is a rare chromosomal abnormality. It is associated with multiple congenital anomalies. We report a 15 year-old female with an unusual karyotype with three cell lines: 47,XX,+mar/47,XX,+14/46,XX. At six months old she had short stature, cleft palate, hyperpigmented linear spots in arms and legs and developmental delay. At present, she has mild facial dysmorphism and moderate mental retardation. Cytogenetic analysis was performed in peripheral blood lymphocytes and in the light and dark skin following standard methods. DNAarray - Oligo 180 k was carried out using Agilent Technologies and FISH analysis was accomplished using DNA BACs probes to confirm the result obtained by DNAarray. Methylation-Specific PCR (MS-PCR) of the MEG3 promoter and microsatellite analysis were performed. Microarray analysis confirmed partial trisomy 14 mosaicism; the marker chromosome was found to be from chromosome 14, the result was confirmed with FISH. Methylation (14q32.3) and microsatellite (14q11-14q32.33) analysis were carried out and UPD was discarded. The global result was: mos 47,XX,+del(14)(q11.2)[45]/47,XX,+14[10]/46,XX[45]. This is a unique case because of the coexistence of two abnormal cell lines, including one with +14 and another with +del(14)(q11.2). To our knowledge, only three patients have been reported with trisomy 14 and another abnormal cell line. The array analysis identified the marker chromosome and characterized the breakpoint. The del(14)(q11.2) does not seem to be related to any particular phenotypic characteristic of the patient; the clinical features of our patient observed until now, can be attributed to trisomy 14 mosaicism. Nevertheless, we cannot discard the manifestation of new symptoms related to her karyotype in the future.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>25276227</pmid><doi>10.1186/s13039-014-0065-8</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1755-8166
ispartof Molecular cytogenetics, 2014-09, Vol.7 (1), p.65, Article 65
issn 1755-8166
1755-8166
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4180134
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry; SpringerLink Journals - AutoHoldings
subjects Case Report
Case studies
DNA microarrays
Genetic aspects
Instrument industry
Mental illness
Risk factors
Skin
title Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T16%3A51%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Partial%20and%20complete%20trisomy%2014%20mosaicism:%20clinical%20follow-up,%20cytogenetic%20and%20molecular%20analysis&rft.jtitle=Molecular%20cytogenetics&rft.au=Salas-Labad%C3%ADa,%20Consuelo&rft.date=2014-09-25&rft.volume=7&rft.issue=1&rft.spage=65&rft.pages=65-&rft.artnum=65&rft.issn=1755-8166&rft.eissn=1755-8166&rft_id=info:doi/10.1186/s13039-014-0065-8&rft_dat=%3Cgale_pubme%3EA540655383%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1566541099&rft_id=info:pmid/25276227&rft_galeid=A540655383&rfr_iscdi=true